{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:10:11Z","timestamp":1791389411175,"version":"4.3.3"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004106","name":"East China Normal University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004106","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.taap.2024.117112","type":"journal-article","created":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T12:29:51Z","timestamp":1727180991000},"page":"117112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Human trophoblast organoids for improved prediction of placental ABC transporter-mediated drug transport"],"prefix":"10.1016","volume":"492","author":[{"given":"Shengbo","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingyi","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanqing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanjin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haichuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuwen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2024.117112_bb0005","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/humupd\/dmaa017","article-title":"Investigation of human trophoblast invasion in vitro","volume":"26","author":"Abbas","year":"2020","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.taap.2024.117112_bb0010","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1097\/AOG.0000000000002357","article-title":"Disparities in chronic conditions among women hospitalized for delivery in the United States, 2005-2014","volume":"130","author":"Admon","year":"2017","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.taap.2024.117112_bb0015","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.bcp.2018.09.012","article-title":"Role of the efflux transporters BCRP and MRP1 in human placental bio-disposition of pravastatin","volume":"156","author":"Afrouzian","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2024.117112_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2022.116344","article-title":"Infection and disruption of placental multidrug resistance (MDR) transporters: implications for fetal drug exposure","volume":"459","author":"Andrade","year":"2023","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2024.117112_bb0025","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1124\/dmd.121.000538","article-title":"Successful prediction of human fetal exposure to P-glycoprotein substrate drugs using the proteomics-informed relative expression factor approach and PBPK modeling and simulation","volume":"49","author":"Anoshchenko","year":"2021","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2024.117112_bb0030","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.addr.2020.08.010","article-title":"Microphysiological systems of the placental barrier","volume":"161-162","author":"Arumugasaamy","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.taap.2024.117112_bb0035","first-page":"164","article-title":"ATP-binding cassette transporters in reproduction: a new frontier","volume":"22","author":"Bloise","year":"2016","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.taap.2024.117112_bb0040","first-page":"201700786","article-title":"Placental drug transport-on-a-Chip: A microengineered in vitro model of transporter-mediated drug efflux in the human placental barrier","volume":"7","author":"Blundell","year":"2018","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.taap.2024.117112_bb0045","doi-asserted-by":"crossref","first-page":"S745","DOI":"10.1016\/j.ajog.2017.11.577","article-title":"Pathophysiology of placental-derived fetal growth restriction","volume":"218","author":"Burton","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.taap.2024.117112_bb0050","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.3389\/fphar.2018.01027","article-title":"Physiology and pathophysiology of steroid biosynthesis, transport and metabolism in the human placenta","volume":"9","author":"Chatuphonprasert","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.taap.2024.117112_bb0055","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.apsb.2019.01.007","article-title":"Development of precision medicine approaches based on inter-individual variability of BCRP\/ABCG2","volume":"9","author":"Chen","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.taap.2024.117112_bb0060","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1186\/s12916-021-02173-4","article-title":"P-gp expression inhibition mediates placental glucocorticoid barrier opening and fetal weight loss","volume":"19","author":"Ge","year":"2021","journal-title":"BMC Med."},{"key":"10.1016\/j.taap.2024.117112_bb0065","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.stemcr.2018.07.004","article-title":"Self-renewing trophoblast organoids recapitulate the developmental program of the early human placenta","volume":"11","author":"Haider","year":"2018","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.taap.2024.117112_bb0070","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/REP-19-0428","article-title":"Modeling human trophoblast, the placental epithelium at the maternal fetal interface","volume":"160","author":"Horii","year":"2020","journal-title":"Reproduction"},{"key":"10.1016\/j.taap.2024.117112_bb0075","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12916-021-01957-y","article-title":"Dexamethasone induces an imbalanced fetal-placental-maternal bile acid circulation: involvement of placental transporters","volume":"19","author":"Huang","year":"2021","journal-title":"BMC Med."},{"key":"10.1016\/j.taap.2024.117112_bb0080","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1021\/mp300410n","article-title":"Comparison of the permeability of metoprolol and labetalol in rat, mouse, and Caco-2 cells: use as a reference standard for BCS classification","volume":"10","author":"Incecayir","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.taap.2024.117112_bb0085","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1007\/s11095-016-2028-8","article-title":"Placental ABC transporters: biological impact and pharmaceutical significance","volume":"33","author":"Joshi","year":"2016","journal-title":"Pharm. Res. Dordr."},{"key":"10.1016\/j.taap.2024.117112_bb0090","doi-asserted-by":"crossref","first-page":"S844","DOI":"10.1016\/j.ajog.2021.11.1356","article-title":"The etiology of preeclampsia","volume":"226","author":"Jung","year":"2022","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.taap.2024.117112_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056525","article-title":"Effects of sertraline and fluoxetine on p-glycoprotein at barrier sites: in vivo and in vitro approaches","volume":"8","author":"Kapoor","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.taap.2024.117112_bb0100","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1007\/s00018-019-03104-6","article-title":"Human placenta and trophoblast development: key molecular mechanisms and model systems","volume":"76","author":"Knofler","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.taap.2024.117112_bb0105","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/17512433.2018.1425615","article-title":"The role of the placenta in drug transport and fetal drug exposure","volume":"11","author":"Koren","year":"2018","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"10.1016\/j.taap.2024.117112_bb0110","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1124\/dmd.121.000449","article-title":"Regulation of placental efflux transporters during pregnancy complications","volume":"50","author":"Kozlosky","year":"2022","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2024.117112_bb0115","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.stemcr.2016.01.006","article-title":"What is trophoblast? A combination of criteria define human first-trimester trophoblast","volume":"6","author":"Lee","year":"2016","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.taap.2024.117112_bb0120","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.phrs.2017.04.007","article-title":"P-gp\/ABCB1 exerts differential impacts on brain and fetal exposure to norbuprenorphine-response to \u2018Letter to the Editor\u2019","volume":"121","author":"Liao","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.taap.2024.117112_bb0125","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.apsb.2022.05.029","article-title":"Developmental toxicity and programming alterations of multiple organs in offspring induced by medication during pregnancy","volume":"13","author":"Lu","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.taap.2024.117112_bb0130","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajog.2011.02.029","article-title":"Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008","volume":"205","author":"Mitchell","year":"2011","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.taap.2024.117112_bb0135","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.tiv.2012.08.027","article-title":"Placental transfer and metabolism: an overview of the experimental models utilizing human placental tissue","volume":"27","author":"Myllynen","year":"2013","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.taap.2024.117112_bb0140","first-page":"690","article-title":"Role of kaempferol to increase bioavailability and pharmacokinetics of nifedipine in rats","volume":"17","author":"Park","year":"2019","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.taap.2024.117112_bb0145","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.phrs.2017.02.024","article-title":"High-content screening of clinically tested anticancer drugs identifies novel inhibitors of human MRP1 (ABCC1)","volume":"119","author":"Peterson","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.taap.2024.117112_bb0150","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ajog.2021.04.227","article-title":"Drug development research in pregnant and lactating women","volume":"225","author":"Ren","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.taap.2024.117112_bb0155","doi-asserted-by":"crossref","first-page":"R179","DOI":"10.1530\/REP-16-0325","article-title":"The evolution of the placenta","volume":"152","author":"Roberts","year":"2016","journal-title":"Reproduction"},{"key":"10.1016\/j.taap.2024.117112_bb0160","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/bdra.23063","article-title":"Cancer chemotherapeutic agents as human teratogens","volume":"94","author":"Selig","year":"2012","journal-title":"Birth Defects Res. A"},{"key":"10.1016\/j.taap.2024.117112_bb0165","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1038\/s41596-020-0381-x","article-title":"Establishment and differentiation of long-term trophoblast organoid cultures from the human placenta","volume":"15","author":"Sheridan","year":"2020","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.taap.2024.117112_bb0170","doi-asserted-by":"crossref","first-page":"dev156273","DOI":"10.1242\/dev.156273","article-title":"Comparative analysis of mouse and human placentae across gestation reveals species-specific regulators of placental development","volume":"145","author":"Soncin","year":"2018","journal-title":"Development"},{"key":"10.1016\/j.taap.2024.117112_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110506","article-title":"Interplay of drug transporters P-glycoprotein (MDR1), MRP1, OATP1A2 and OATP1B3 in passage of maraviroc across human placenta","volume":"129","author":"Tupova","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.taap.2024.117112_bb0180","doi-asserted-by":"crossref","first-page":"dev163428","DOI":"10.1242\/dev.163428","article-title":"Development of the human placenta","volume":"146","author":"Turco","year":"2019","journal-title":"Development"},{"key":"10.1016\/j.taap.2024.117112_bb0185","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41586-018-0753-3","article-title":"Trophoblast organoids as a model for maternal-fetal interactions during human placentation","volume":"564","author":"Turco","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.taap.2024.117112_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(00)00743-3","article-title":"Human placental transport of vinblastine, vincristine, digoxin and progesterone: contribution of P-glycoprotein","volume":"408","author":"Ushigome","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.taap.2024.117112_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2017.02.020","article-title":"Targeted pharmacotherapies for defective ABC transporters","volume":"136","author":"Vauthier","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2024.117112_bb0200","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1742-7843.2008.00298.x","article-title":"Antipsychotic drugs inhibit the function of breast cancer resistance protein","volume":"103","author":"Wang","year":"2008","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.taap.2024.117112_bb0205","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ajog.2021.02.032","article-title":"Obstetrical, fetal, and lactation pharmacology-a crisis that can no longer be ignored","volume":"225","author":"Wesley","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.taap.2024.117112_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2021.115735","article-title":"P-glycoprotein mediates the pharmacokinetic interaction of olanzapine with fluoxetine in rats","volume":"431","author":"Xu","year":"2021","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2024.117112_bb0215","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1080\/10717544.2017.1381199","article-title":"A novel biosensor based on intestinal 3D organoids for detecting the function of BCRP","volume":"24","author":"Zhang","year":"2017","journal-title":"Drug Deliv."},{"key":"10.1016\/j.taap.2024.117112_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2019.104449","article-title":"Characterization of in vitro Mrp2 transporter model based on intestinal organoids","volume":"108","author":"Zhang","year":"2019","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.taap.2024.117112_bb0225","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/j.apsb.2020.12.002","article-title":"3D organoids derived from the small intestine: an emerging tool for drug transport research","volume":"11","author":"Zhang","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.taap.2024.117112_bb0230","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/bcpt.12680","article-title":"A novel model of P-glycoprotein inhibitor screening using human small intestinal organoids","volume":"120","author":"Zhao","year":"2017","journal-title":"Basic Clin. Pharmacol."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X24003119?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X24003119?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:12:15Z","timestamp":1777457535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X24003119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":46,"alternative-id":["S0041008X24003119"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2024.117112","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human trophoblast organoids for improved prediction of placental ABC transporter-mediated drug transport","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2024.117112","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117112"}}